Single on-chip gold nanowires for electrochemical biosensing of glucose

The development of glucose diagnostic devices with low detection limits is of key importance in diabetes-related research. New highly sensitive sensors are required for non-invasive detection of glucose in bodily fluids, other than blood, and an electrochemical sensor based on a single gold nanowire for rapid, reliable and quantitative detection of low glucose concentrations (10 μM-1 mM), is presented in this paper. Single gold nanowire devices are fabricated at silicon chip substrates using a hybrid electron beam-photolithography approach. Critical dimensions of the nanowires are characterised using a combination of scanning electron and atomic force microscopies. Fabricated nanowire devices are characterised by direct electrical probing and cyclic voltammetry to explore functionality. The voltammetric detection of glucose was performed using ferrocene monocarboxylic acid as an oxidising mediator in the presence of glucose oxidase. The biosensor can be applied to the quantification of glucose in the range of 10 μM-100 mM, with an extremely high sensitivity of 7.2 mA mM(-1) cm(-2) and a low detection limit of 3 μM (S/N = 3). The sensor demonstrated high selectivity towards glucose with negligible interference from other oxidizable species including uric acid, ascorbic acid, mannose, fructose, salicylic acid (Aspirin) and acetaminophen (Paracetamol).     

Visible and near-IR luminescence via energy transfer in rare earth doped mesoporous titania thin films with nanocrystalline walls

Selected photoluminescence in the wavelength range of 600-1540 nm is generated by energy transfer from a light-gathering mesostructured host lattice to an appropriate rare earth ion. The mesoporous titania thin films, which have a well-ordered pore structure and two-phase walls made of amorphous titania and TiO₂ nanocrystallites, were doped with up to 8 mol% lanthanide ions, and the ordered structure of the material was preserved. Exciting the titania in its band gap results in energy transfer and it is possible to observe photoluminescence from the crystal field states of the rare earth ions. This process is successful for certain rare earth ions (Sm³⁺, Eu³⁺, Yb³⁺, Nd³⁺, Er³⁺) and not for others (Tb³⁺, Tm³⁺). A mechanism has been proposed to explain this phenomenon, which involves energy transfer through surface states on titania nanocrystals to matching electronic states on the rare earth ions.     

Comparative inhibition by substrate analogues 3-methoxy- and 3-hydroxydesaminokynurenine and an improved 3 step purification of recombinant human kynureninase.

Background  

Kynureninase is a key enzyme on the kynurenine pathway of tryptophan metabolism. One of the end products of the pathway is the neurotoxin quinolinic acid which appears to be responsible for neuronal cell death in a number of important neurological diseases. This makes kynureninase a possible therapeutic target for diseases such as Huntington's, Alzheimer's and AIDS related dementia, and the development of potent inhibitors an important research aim.     

Mixed valence in YBaFe(2)O(5)

YBaFe(2)O(5) has been synthesized by heating a nanoscale citrate precursor in a carefully controlled reducing environment. Successful synthesis of a single-phase sample can only be achieved in a narrow window of oxygen partial pressures and temperatures. YBaFe(2)O(5) adopts an oxygen-deficient perovskite-type structure, which contains double layers of corner sharing FeO(5) square pyramids separated by Y(3+) ions. At T(N) congruent with 430 K, tetragonal (P4/mmm) and paramagnetic YBaFe(2)O(5) orders antiferromagnetically (AFM) experiencing a slight orthorhombic distortion (Pmmm). Around this temperature, it can be characterized as a class-III mixed valence (MV) compound, where all iron atoms exist as equivalent MV Fe(2.5+) ions. The magnetic structure is characterized by AFM Fe-O-Fe superexchange coupling within the double layers and a ferromagnetic Fe-Fe direct-exchange coupling between neighboring double layers. Upon cooling below approximately 335 K, a premonitory charge ordering (2Fe(2.5+) --> Fe(2.5+delta) + Fe(2.5)(-delta)) into a class-II MV phase takes place. This transition is detected by differential scanning calorimetry, but powder diffraction techniques fail to detect any volume change or a long-range structural order. At approximately 308 K, a complete charge ordering (2Fe(2.5+) --> Fe(2+) + Fe(3+)) into a class-I MV compound takes place. This charge localization triggers a number of changes in the crystal, magnetic, and electronic structure of YBaFe(2)O(5). The magnetic structure rearranges to a G-type AFM structure, where both the Fe-O-Fe superexchange and the Fe-Fe direct-exchange couplings are antiferromagnetic. The crystal structure rearranges (Pmma) to accommodate alternating chains of Fe(2+) and Fe(3+) running along b and an unexpectedly large cooperative Jahn-Teller distortion about the high-spin Fe(2+) ions. This order of charges does not fulfill the Anderson condition, and it rather corresponds to an ordering of doubly occupied Fe(2+) d(xz) orbitals. Comparisons with YBaMn(2)O(5) and YBaCo(2)O(5) are made to highlight the impact of changing the d-electron count.     

CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activity

[reaction: see text] A novel approach to alpha,alpha-disubstituted-beta-amino acids (beta(2,2)-amino acids) was employed in the synthesis of a series of 3-(pyrrolidin-1-yl)propionic acids possessing high affinity for the CCR5 receptor and potent anti-HIV activity. The rat pharmacokinetics for these new analogues featured higher bioavailabilities and lower rates of clearance as compared to cyclopentane 1.     

Factors affecting atrazine concentration and quantitative determination in chlorinated water

Although the herbicide atrazine has been reported to not react measurably with free chlorine during drinking water treatment, this work demonstrates that at contact times consistent with drinking water distribution system residence times, a transformation of atrazine can be observed. Some transformation products detected through the use of high performance liquid chromatography–electrospray mass spectrometry are consistent with the formation of N-chloro atrazine. The effects of applied chlorine, pH, and reaction time on the transformation reaction were studied to help understand the practical implications of the transformation on the accurate determination of atrazine in drinking waters. The errors in the determination of atrazine are a function of the type of dechlorinating agent applied during sample preparation and the analytical instrumentation utilized. When a reductive dechlorinating agent, such as sodium sulfite or ascorbic acid is used, the quantification of the atrazine can be inaccurate, ranging from 2-fold at pH 7.5 to 30-fold at pH 6.0. The results suggest HPLC/UV and ammonium chloride quenching may be best for accurate quantification. Hence, the results also appear to have implications for both compliance monitoring and health effects studies that utilize gas chromatography analysis with sodium sulfite or ascorbic acid as the quenching agent.     

Design aspects for the development of mixed-metal supramolecular complexes capable of visible light induced photocleavage of DNA

Mixed-metal supramolecular complexes that couple ruthenium or osmium based light absorbers to a central rhodium(III) core have been designed which photocleave DNA upon irradiation with visible light. The complexes [[(bpy)(2)Ru(dpp)](2)RhCl(2)](PF(6))(5), [[(bpy)(2)Os(dpp)](2)RhCl(2)](PF(6))(5), and [[(tpy)RuCl(dpp)](2)RhCl(2)](PF(6))(3), where bpy = 2,2'-bipyridine, tpy = 2,2':6',2' '-terpyridine, and dpp = 2,3-bis(2-pyridyl)pyrazine, all exhibit intense metal to ligand charge transfer (MLCT) based transitions in the visible but possess lower lying metal to metal charge transfer (MMCT) excited states. These supramolecular complexes with low lying MMCT states photocleave DNA when excited into their intense MLCT transitions. Structurally similar complexes without this low lying MMCT state do not exhibit DNA photocleavage, establishing the role of this MMCT state in the DNA photocleavage event. Design considerations necessary to produce functional DNA photocleavage agents are presented herein.     

An evaluation of exogenous application of protoporphyrin IX and its dimethyl ester as a photodynamic diagnostic agent in poorly differentiated human nasopharyngeal carcinoma

5-Aminolevulinic acid and its esterified analogues have been under much investigation to enhance the endogenous production of protoporphyrin IX (PpIX) in tumor cells. However, in this work, we studied the in vitro and in vivo efficacy of exogenously administered PpIX and its esterified analogue, PpIX dimethyl ester (PME), in poorly differentiated human nasopharyngeal carcinoma (NPC/CNE-2) as a photodynamic diagnostic (PDD) agent. NPC/CNE-2 at its earliest time, 1 h after incubation with PME in in vitro studies, has exhibited 64% (P <0.01) higher tumor to normal cell (T/N) fluorescence ratio than with PpIX. In an in vivo mouse xenograft model, comparable photosensitizer concentration in tumor after intravenous administration was observed at 1-3 h time points, but at 9 h, PME had 31% (P=0.05) greater concentration in tumor compared with PpIX. In addition, by constituting PME and PpIX in different topical gel composites, of which, PME gel composition of 8:2 Plasdone and Gantrez resulted in the highest T/N ratio at 6 h after application (34%; P <0.05) in comparison with other gel composites. Evaluation of PME and PpIX constituted in the delivery vehicles investigated showed comparable selectivity for tumor at 1-3 h, thus neither photosensitizer is more efficient than the other for PDD at the early time points; however, beyond 6 h, PME had higher selectivity for tumor compared with PpIX. Thus, further investigation is warranted to improve the drug delivery vehicle for greater tumor selectivity at a shorter incubation time.     

Unusual photophysical switching in a Ru(II) diimine DNA probe caused by amide functionalisation

Whereas the complex [Ru(phen)2Medpq]2+(phen=1,10-phenanthroline; Medpq=2-methyldipyrido[3,2-f:2',3'-h]-quinoxaline) is luminescent in both aqueous and nonaqueous solutions, [Ru(phen)2dpqa]2+(2-pentylamidodipyrido[3,2-f:2',3'-h]-quinoxaline) does not emit in water but does so strongly in organic solvents or when bound to DNA--suggesting its use as a photochemical and photophysical probe for nucleic acids.